EdgarLookup

AGREE REALTY CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that AGREE REALTY CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
28.4%
Profit Margin
Net income ÷ revenue
2.1%
Return on Assets
Net income ÷ assets
0.56x
Debt-to-Equity
Total liabilities ÷ equity
+16.4%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $718.40M Feb 10, 2026
FY2025 Dec 31, 2024 $617.10M Feb 10, 2026
FY2025 Dec 31, 2023 $537.50M Feb 10, 2026
FY2024 Dec 31, 2022 $429.81M Feb 11, 2025
FY2023 Dec 31, 2021 $339.32M Feb 13, 2024
FY2022 Dec 31, 2020 $248.57M Feb 14, 2023
FY2019 Dec 31, 2019 $52.14M Feb 20, 2020
FY2019 Sep 30, 2019 $48.08M Feb 20, 2020
FY2019 Jun 30, 2019 $44.92M Feb 20, 2020
FY2019 Mar 31, 2019 $42.35M Feb 20, 2020

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $204.35M Feb 10, 2026
FY2025 Dec 31, 2024 $189.20M Feb 10, 2026
FY2025 Dec 31, 2023 $169.96M Feb 10, 2026
FY2024 Dec 31, 2022 $152.44M Feb 11, 2025
FY2023 Dec 31, 2021 $122.27M Feb 13, 2024
FY2022 Dec 31, 2020 $91.38M Feb 14, 2023
FY2019 Dec 31, 2019 $22.56M Feb 20, 2020
FY2019 Sep 30, 2019 $20.61M Feb 20, 2020
FY2019 Jun 30, 2019 $18.56M Feb 20, 2020
FY2019 Mar 31, 2019 $18.35M Feb 20, 2020

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $340.40M Feb 10, 2026
FY2025 Dec 31, 2024 $302.24M Feb 10, 2026
FY2025 Dec 31, 2023 $254.39M Feb 10, 2026
FY2024 Dec 31, 2022 $218.09M Feb 11, 2025
FY2023 Dec 31, 2021 $190.27M Feb 13, 2024
FY2022 Dec 31, 2020 $133.13M Feb 14, 2023
FY2021 Dec 31, 2019 $114.40M Feb 22, 2022
FY2020 Dec 31, 2018 $73.01M Feb 18, 2021
FY2019 Dec 31, 2017 $62.96M Feb 20, 2020
FY2018 Dec 31, 2016 $51.66M Feb 21, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $504.14M Feb 10, 2026
FY2025 Dec 31, 2024 $431.97M Feb 10, 2026
FY2025 Dec 31, 2023 $391.60M Feb 10, 2026
FY2024 Dec 31, 2022 $362.12M Feb 11, 2025
FY2023 Dec 31, 2021 $246.32M Feb 13, 2024
FY2022 Dec 31, 2020 $142.96M Feb 14, 2023
FY2021 Dec 31, 2019 $126.71M Feb 22, 2022
FY2020 Dec 31, 2018 $93.25M Feb 18, 2021
FY2019 Dec 31, 2017 $82.20M Feb 20, 2020
FY2018 Dec 31, 2016 $61.74M Feb 21, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2024 Dec 31, 2024 $874.50M Feb 11, 2025
FY2024 Dec 31, 2023 $1.20B Feb 11, 2025
FY2023 Dec 31, 2022 $1.60B Feb 13, 2024
FY2022 Dec 31, 2021 $1.39B Feb 14, 2023
FY2021 Dec 31, 2020 $1.31B Feb 22, 2022
FY2020 Dec 31, 2019 $702.90M Feb 18, 2021
FY2019 Dec 31, 2018 $608.30M Feb 20, 2020

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $9.80B Feb 10, 2026
FY2025 Dec 31, 2024 $8.49B Feb 10, 2026
FY2024 Dec 31, 2023 $7.77B Feb 11, 2025
FY2023 Dec 31, 2022 $6.71B Feb 13, 2024
FY2022 Dec 31, 2021 $5.23B Feb 14, 2023
FY2021 Dec 31, 2020 $3.89B Feb 22, 2022
FY2020 Dec 31, 2019 $2.66B Feb 18, 2021
FY2019 Dec 31, 2018 $2.03B Feb 20, 2020
FY2018 Dec 31, 2017 $1.49B Feb 21, 2019
FY2017 Dec 31, 2016 $1.14B Feb 22, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.53B Feb 10, 2026
FY2025 Dec 31, 2024 $2.98B Feb 10, 2026
FY2024 Dec 31, 2023 $2.57B Feb 11, 2025
FY2023 Dec 31, 2022 $2.08B Feb 13, 2024
FY2022 Dec 31, 2021 $1.81B Feb 14, 2023
FY2021 Dec 31, 2020 $1.36B Feb 22, 2022
FY2020 Dec 31, 2019 $972.97M Feb 18, 2021
FY2019 Dec 31, 2018 $789.70M Feb 20, 2020
FY2018 Dec 31, 2017 $583.44M Feb 21, 2019
FY2017 Dec 31, 2016 $456.46M Feb 22, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $6.27B Feb 10, 2026
FY2025 Dec 31, 2024 $5.51B Feb 10, 2026
FY2024 Dec 31, 2023 $5.20B Feb 11, 2025
FY2023 Dec 31, 2022 $4.63B Feb 13, 2024
FY2022 Dec 31, 2021 $3.42B Feb 14, 2023
FY2021 Dec 31, 2020 $2.52B Feb 22, 2022
FY2020 Dec 31, 2019 $1.69B Feb 18, 2021
FY2019 Dec 31, 2018 $1.24B Feb 20, 2020
FY2018 Dec 31, 2017 $908.66M Feb 21, 2019
FY2017 Dec 31, 2016 $682.98M Feb 22, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2014 Dec 31, 2014 ($32.58M) Mar 6, 2015
FY2014 Dec 31, 2013 ($23.88M) Mar 6, 2015
FY2013 Dec 31, 2012 ($21.17M) Mar 7, 2014
FY2012 Dec 31, 2011 ($20.92M) Mar 11, 2013
FY2011 Dec 31, 2010 ($14.70M) Mar 12, 2012

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $16.30M Feb 10, 2026
FY2025 Dec 31, 2024 $6.40M Feb 10, 2026
FY2024 Dec 31, 2023 $10.91M Feb 11, 2025
FY2023 Dec 31, 2022 $27.76M Feb 13, 2024
FY2022 Dec 31, 2021 $43.25M Feb 14, 2023
FY2021 Dec 31, 2020 $6.14M Feb 22, 2022
FY2020 Dec 31, 2019 $15.60M Feb 18, 2021
FY2019 Dec 31, 2018 $53.96M Feb 20, 2020
FY2018 Dec 31, 2017 $50.81M Feb 21, 2019
FY2017 Dec 31, 2016 $33.40M Feb 22, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2021 Dec 31, 2021 $1.69B Feb 22, 2022
FY2020 Dec 31, 2020 $1.23B Feb 18, 2021
FY2018 Dec 31, 2018 $724.06M Feb 21, 2019
FY2017 Dec 31, 2017 $522.40M Feb 22, 2018
FY2016 Dec 31, 2016 $404.05M Feb 23, 2017
FY2015 Dec 31, 2015 $319.58M Mar 11, 2016
FY2014 Dec 31, 2014 $221.76M Mar 6, 2015
FY2013 Dec 31, 2013 $158.40M Mar 7, 2014
FY2012 Dec 31, 2012 $117.38M Mar 11, 2013

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 10, 2026
FY2025 Dec 31, 2024 1 Feb 10, 2026
FY2025 Dec 31, 2023 1 Feb 10, 2026
FY2024 Dec 31, 2022 1 Feb 11, 2025
FY2023 Dec 31, 2021 1 Feb 13, 2024
FY2022 Dec 31, 2020 1 Feb 14, 2023
FY2019 Dec 31, 2019 0 Feb 20, 2020
FY2019 Sep 30, 2019 0 Feb 20, 2020
FY2019 Jun 30, 2019 0 Feb 20, 2020
FY2019 Mar 31, 2019 0 Feb 20, 2020

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 10, 2026
FY2025 Dec 31, 2024 1 Feb 10, 2026
FY2025 Dec 31, 2023 1 Feb 10, 2026
FY2024 Dec 31, 2022 1 Feb 11, 2025
FY2023 Dec 31, 2021 1 Feb 13, 2024
FY2022 Dec 31, 2020 1 Feb 14, 2023
FY2019 Dec 31, 2019 0 Feb 20, 2020
FY2019 Sep 30, 2019 0 Feb 20, 2020
FY2019 Jun 30, 2019 0 Feb 20, 2020
FY2019 Mar 31, 2019 0 Feb 20, 2020

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 120.03M Feb 10, 2026
FY2025 Dec 31, 2024 107.25M Feb 10, 2026
FY2024 Dec 31, 2023 100.52M Feb 11, 2025
FY2023 Dec 31, 2022 90.17M Feb 13, 2024
FY2022 Dec 31, 2021 71.29M Feb 14, 2023
FY2021 Dec 31, 2020 60.02M Feb 22, 2022
FY2020 Dec 31, 2019 45.57M Feb 18, 2021
FY2019 Dec 31, 2018 37.55M Feb 20, 2020
FY2018 Dec 31, 2017 31.00M Feb 21, 2019
FY2017 Dec 31, 2016 26.16M Feb 22, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $340.65M Feb 10, 2026
FY2025 Dec 31, 2024 $303.60M Feb 10, 2026
FY2025 Dec 31, 2023 $277.68M Feb 10, 2026
FY2024 Dec 31, 2022 $220.30M Feb 11, 2025
FY2023 Dec 31, 2021 $194.30M Feb 13, 2024
FY2022 Dec 31, 2020 $116.11M Feb 14, 2023
FY2021 Dec 31, 2019 $90.26M Feb 22, 2022
FY2020 Dec 31, 2018 $67.64M Feb 18, 2021
FY2019 Dec 31, 2017 $55.15M Feb 20, 2020
FY2018 Dec 31, 2016 $42.06M Feb 21, 2019